[The protective activity of polyclonal and monoclonal antibodies to the lipopolysaccharide of Neisseria meningitidis serogroup A in in vivo experiments].
The protective activity of the sera of mice immunized with the preparations of native and detoxified N. meningitidis lipopolysaccharide (LPS), group A, as well as with monoclonal antibodies to N. meningitidis antigens, groups A and B, was studied on the mucin model of meningococcal infection. The study showed that the maximum level of anti-LPS antibodies in mice was observed on day 7 after the injection of LPS. Immune sera obtained from mice were capable of protecting the animals from fetal meningococcemia induced by N. meningitidis strains of homologous and heterologous groups. As shown by the results of this study, the alkaline treatment of N. meningitidis native LPS did not decrease the protective properties of antibodies. The monoclonal antibodies under study were found to possess high preventive activity in mice challenged with N. meningitidis, groups A and B. Anti-LPS monoclonal antibodies showed greater protective activity than antipolysaccharide monoclonal antibodies.
Del'vig
A A
AA
Krasnoproshina
L I
LI
Volgareva
G M
GM
Bobyleva
G V
GV
Kuvakina
V I
VI
Artem'eva
T A
TA
D000818:Animals; D000907:Antibodies, Bacterial / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D007114:Immunization; D007116:Immunization, Passive; D008070:Lipopolysaccharides / Q000276:immunology*; D008585:Meningitis, Meningococcal / Q000517:prevention & control; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009345:Neisseria meningitidis / Q000276:immunology*; D018805:Sepsis / Q000517:prevention & control
D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides
Protektivnaia aktivnost' poliklonal'nykh i monoklonal'nykh antitel k lipopolisakharidu Neisseria meningitidis serogruppy A v opytakh in vivo.